Tag: urinary tract infection testing devices market

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Urinary Tract Infection Testing Devices Market Expansion Outlook: What Revenue Opportunities Are Ahead?

The urinary tract infection testing devices market size has shown significant growth in recent years. It is projected to expand from $0.66 billion in 2025 to $0.71 billion in 2026, at a compound annual growth rate (CAGR) of 6.3%. The historical period’s growth can be attributed to the high prevalence of UTIs, the increasing diagnostic workload in hospitals, the adoption of routine urinalysis, the demand for quicker diagnoses, and the expansion of diagnostic laboratories.

The urinary tract infection testing devices market is set for significant expansion in the coming years. It is projected to achieve a valuation of $0.9 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.2%. This anticipated growth during the forecast period can be linked to the increased prevalence of point-of-care testing, the emergence of AI-assisted urine analysis, the expansion of home diagnostics, escalating concerns over antimicrobial resistance, and breakthroughs in rapid diagnostic kits. Key trends expected in this period include rapid point-of-care UTI testing, the adoption of automated urinalysis systems, the availability of home-based UTI testing kits, improvements in bacterial detection accuracy, and antibiotic susceptibility screening.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=20833090&type=smp&name=Urinary%20Tract%20Infection%20Testing%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Urinary Tract Infection Testing Devices Market Growth Momentum: What Factors Are Shaping Demand?

The increasing occurrence of urinary tract infections (UTIs) is projected to boost the expansion of the urinary tract infection testing devices market moving forward. UTIs are infections affecting any part of the urinary system, such as the kidneys, ureters, bladder, or urethra, predominantly caused by bacteria, with Escherichia coli being the most frequent pathogen. The rising prevalence of these infections stems from factors like extended catheter usage, poor hygiene practices, and heightened antimicrobial resistance among hospital patients. Urinary tract infection testing devices play a crucial role in aiding patients with UTIs by facilitating quick and precise diagnoses, which enables healthcare professionals to pinpoint the exact pathogens and provide timely, targeted treatments. This, in turn, helps to lessen complications, enhance patient recovery, and curb the spread of antimicrobial resistance within healthcare environments. As an illustration, in March 2024, the University of New South Wales, an Australia-based public research university, reported that UTIs are widespread infections, with a global incidence estimated at over 400 million cases annually. Consequently, the increasing prevalence of urinary tract infections (UTIs) fuels the urinary tract infection testing devices market.

Urinary Tract Infection Testing Devices Market Segment Landscape: Which Areas Lead Development?

The urinary tract infection testing devices market covered in this report is segmented –

1) By Product type: Instruments, Kits

2) By Test Type: Urinalysis, Urine Cultures, Susceptibility Testing

3) By End-User: Hospitals, Diagnostic Labs, Other End Users

Subsegments:

1) By Instruments: Automated UTI Analyzers, UTI Culture Systems, UTI Microscopes, UTI Diagnostic Devices (Handheld Devices)

2) By Kits: UTI Test Strips, UTI Reagents, Urine Culture Kits, UTI Home Testing Kits

Urinary Tract Infection Testing Devices Market Trends Redefining Industry Growth

Major companies engaged in the urinary tract infection testing devices market are prioritizing point-of-care (POC) testing devices to facilitate swifter and more convenient diagnoses, thereby improving patient outcomes. Point-of-care (POC) testing devices refer to medical diagnostic assessments conducted at or near the patient’s location of care, such as within a doctor’s clinic, at a hospital bedside, or even in a home environment, without the requirement to send samples to an external laboratory. For example, in June 2023, Sysmex Corporation, a Japan-based entity manufacturing urinary tract infection testing devices, unveiled the PA-100 AST System, a Point-of-Care Testing System designed for detecting antimicrobial susceptibility. This particular system can identify the presence or absence of bacteria and assess how effective antimicrobials are within a short processing period. It reports the identification of growing bacteria in urine samples in approximately 10 minutes and provides susceptibility test results in under 30 minutes. This functionality allows healthcare professionals to perform quick testing directly from urine samples taken from patients suspected of having UTIs.

Urinary Tract Infection Testing Devices Market Leading Players And Competitive Positioning

Major companies operating in the urinary tract infection testing devices market are Cardinal Health Inc., F. Hoffmann‑La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, bioMérieux SA, Bio‑Rad Laboratories, QIAGEN NV, Sysmex Corporation, Quidel Corporation, ACON Laboratories Inc., Randox Laboratories Ltd., ARKRAY Inc., T2 Biosystems Inc., Cepheid, Meridian Bioscience Inc., Luminex Corporation, Beckman Coulter Inc., OraSure Technologies Inc., Mesa Biotech Inc.

View The Full Urinary Tract Infection Testing Devices Market Report:

https://thebusinessresearchcompany.com/report/urinary-tract-infection-testing-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Urinary Tract Infection Testing Devices Market Regional Split: Which Areas Are Fueling Growth?

North America was the largest region in the urinary tract infection testing devices market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urinary tract infection testing devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Urinary Tract Infection Testing Devices Market From 2026 To 2030?

The urinary tract infection testing devices market size has shown strong growth in recent years. It is anticipated to increase from $0.66 billion in 2025 to $0.71 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.3%. This historical expansion can be attributed to several factors including the high prevalence of UTIs, growth in hospital diagnostic workloads, the widespread adoption of routine urinalysis, the increasing demand for faster diagnosis, and the expansion of diagnostic laboratories.

The urinary tract infection testing devices market is set to experience significant expansion over the next few years, with projections indicating it will reach $0.9 billion by 2030, advancing at a compound annual growth rate (CAGR) of 6.2%. The anticipated growth within this period is attributed to several factors, including the expansion of point-of-care testing, the emergence of AI-assisted urine analysis, the rise in home diagnostics, increasing concerns about antimicrobial resistance, and ongoing innovation in rapid diagnostic kits. Major developments expected during the forecast period include rapid point-of-care UTI testing, the deployment of automated urinalysis systems, the availability of home-based UTI testing kits, improvements in bacterial detection accuracy, and enhanced antibiotic susceptibility screening.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/urinary-tract-infection-testing-devices-global-market-report

What Key Factors Are Affecting The Urinary Tract Infection Testing Devices Market Demand?

The increasing occurrence of urinary tract infections (UTIs) is projected to drive the expansion of the urinary tract infection testing devices market. UTIs are infections affecting any part of the urinary system, such as the kidneys, ureters, bladder, or urethra, primarily caused by bacteria, with Escherichia coli being the most common. The rise in UTI cases stems from factors like extended catheter use, poor hygiene, and heightened antimicrobial resistance in hospital environments. Urinary tract infection testing devices assist patients by providing quick and precise diagnosis, enabling medical professionals to pinpoint the exact pathogens and deliver timely, targeted treatments. This helps in reducing complications, enhancing patient outcomes, and curbing the spread of antimicrobial resistance in healthcare facilities. For example, in March 2024, the University of New South Wales reported that UTIs are widespread, with an estimated global incidence of over 400 million cases per year. Consequently, the increasing prevalence of urinary tract infections (UTIs) propels the urinary tract infection testing devices market.

How Is The Urinary Tract Infection Testing Devices Market Categorized Across Its Segment Groups?

The urinary tract infection testing devices market covered in this report is segmented –

1) By Product type: Instruments, Kits

2) By Test Type: Urinalysis, Urine Cultures, Susceptibility Testing

3) By End-User: Hospitals, Diagnostic Labs, Other End Users

Subsegments:

1) By Instruments: Automated UTI Analyzers, UTI Culture Systems, UTI Microscopes, UTI Diagnostic Devices (Handheld Devices)

2) By Kits: UTI Test Strips, UTI Reagents, Urine Culture Kits, UTI Home Testing Kits

What Trends Are Influencing Changes In The Urinary Tract Infection Testing Devices Market?

Leading companies in the urinary tract infection testing devices market are increasingly focusing on point-of-care (POC) testing devices to facilitate quicker, more convenient diagnoses and improve patient outcomes. Point-of-care (POC) testing devices refer to medical diagnostic tests conducted at or near the patient’s location of care, such as in a doctor’s office, at a hospital bedside, or even within a home setting, removing the necessity of laboratory sample submission. For example, in June 2023, Sysmex Corporation, a Japan-based company specializing in urinary tract infection testing devices, introduced the PA-100 AST System, a Point-of-Care Testing System aimed at detecting antimicrobial susceptibility. This system is capable of identifying the presence or absence of bacteria and evaluating antimicrobial effectiveness within a short timeframe. It reports the presence of proliferating bacteria in urine samples in approximately 10 minutes and yields susceptibility test results in under 30 minutes, thereby enabling healthcare professionals to perform rapid testing directly from the urine samples of patients suspected of having UTIs.

Which Firms Are Influencing Competition In The Urinary Tract Infection Testing Devices Market?

Major companies operating in the urinary tract infection testing devices market are Cardinal Health Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, bioMérieux SA, Bio-Rad Laboratories, QIAGEN NV, Sysmex Corporation, Quidel Corporation, ACON Laboratories Inc., Randox Laboratories Ltd., ARKRAY Inc., T2 Biosystems Inc., Cepheid, Meridian Bioscience Inc., Luminex Corporation, Beckman Coulter Inc., OraSure Technologies Inc., Mesa Biotech Inc.

Get The Full Urinary Tract Infection Testing Devices Market Report:

https://www.thebusinessresearchcompany.com/report/urinary-tract-infection-testing-devices-global-market-report

Which Region Accounts For The Largest Portion Of The Urinary Tract Infection Testing Devices Market?

North America was the largest region in the urinary tract infection testing devices market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urinary tract infection testing devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Urinary Tract Infection Testing Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/urinary-tract-infection-testing-devices-global-market-report

Browse Through More Reports Similar to the Global Urinary Tract Infection Testing Devices Market 2026, By The Business Research Company

Medical Device Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-device-testing-global-market-report

Urinary Tract Infection Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/urinary-tract-infection-treatment-global-market-report

Medical Device Testing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-device-testing-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Urinary Tract Infection Testing Devices Market Over The 2026–2030 Period?

The urinary tract infection testing devices market has demonstrated significant growth over recent years. It is anticipated to expand from $0.66 billion in 2025 to $0.71 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.3%. This past growth can be attributed to several factors, including the high occurrence of UTIs, an increase in hospital diagnostic workloads, the widespread adoption of routine urinalysis, a rising demand for quicker diagnoses, and the continuous expansion of diagnostic laboratories.

The urinary tract infection testing devices market is set to experience robust expansion in the near future. This market is expected to achieve a size of $0.9 billion in 2030, growing at a compound annual growth rate (CAGR) of 6.2%. The anticipated growth during the forecast period stems from the broader implementation of point-of-care testing, the emergence of AI-assisted urine analysis, the expansion of home diagnostics, increasing worries about antimicrobial resistance, and breakthroughs in rapid diagnostic kits. Significant trends projected for this period involve quick point-of-care UTI testing, automated urinalysis systems, the availability of home-based UTI testing kits, greater precision in bacterial detection, and improved antibiotic susceptibility screening.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20988&type=smp

What Drivers Are Expected To Influence The Urinary Tract Infection Testing Devices Market During The Forecast Period?

The increasing occurrence of urinary tract infections (UTIs) is projected to stimulate the expansion of the urinary tract infection testing devices market in the foreseeable future. UTIs are infections affecting any component of the urinary system, such as the kidneys, ureters, bladder, or urethra, predominantly caused by bacteria, with Escherichia coli frequently identified as the primary pathogen. This escalating incidence of UTIs stems from factors like extended catheterization, insufficient hygiene, and heightened antimicrobial resistance observed in hospitalized individuals. Urinary tract infection testing devices assist UTI patients by providing swift and precise diagnoses, empowering healthcare professionals to pinpoint the specific pathogens and deliver appropriate treatments without delay. This, in turn, lessens complications, enhances patient recovery, and curtails the dissemination of antimicrobial resistance within medical environments. As an illustration, in March 2024, data from the University of New South Wales, an Australia-based public research university, revealed that UTIs are widespread infections, with an estimated global incidence surpassing 400 million cases annually. Consequently, the increasing prevalence of urinary tract infections (UTIs) serves as a key driver for the urinary tract infection testing devices market.

How Is The Urinary Tract Infection Testing Devices Market Segmented Across Key Categories?

The urinary tract infection testing devices market covered in this report is segmented –

1) By Product type: Instruments, Kits

2) By Test Type: Urinalysis, Urine Cultures, Susceptibility Testing

3) By End-User: Hospitals, Diagnostic Labs, Other End Users

Subsegments:

1) By Instruments: Automated UTI Analyzers, UTI Culture Systems, UTI Microscopes, UTI Diagnostic Devices (Handheld Devices)

2) By Kits: UTI Test Strips, UTI Reagents, Urine Culture Kits, UTI Home Testing Kits

Which Upcoming Trends Are Expected To Influence The Urinary Tract Infection Testing Devices Market?

Key companies operating in the urinary tract infection testing devices market are increasingly concentrating on point-of-care (POC) testing devices to achieve faster, more convenient diagnoses and improve patient outcomes. Point-of-care (POC) testing devices are medical diagnostic tools used at or near the patient care location, such as a doctor’s office, a hospital bedside, or even at home, removing the necessity of sending samples to a laboratory. For example, in June 2023, Sysmex Corporation, a Japan-based company producing urinary tract infection testing devices, unveiled the PA-100 AST System, a Point-of-Care Testing System engineered for detecting antimicrobial susceptibility. This system efficiently identifies the presence or absence of bacteria and evaluates antimicrobial effectiveness within a brief timeframe. It provides results for the presence of growing bacteria in urine samples in approximately 10 minutes and offers susceptibility test results in under 30 minutes. This innovation allows healthcare professionals to conduct rapid testing directly from urine samples of individuals suspected of having UTIs.

Who Are The Dominant Players Shaping The Urinary Tract Infection Testing Devices Market Landscape?

Major companies operating in the urinary tract infection testing devices market are Cardinal Health Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, bioMérieux SA, Bio-Rad Laboratories, QIAGEN NV, Sysmex Corporation, Quidel Corporation, ACON Laboratories Inc., Randox Laboratories Ltd., ARKRAY Inc., T2 Biosystems Inc., Cepheid, Meridian Bioscience Inc., Luminex Corporation, Beckman Coulter Inc., OraSure Technologies Inc., Mesa Biotech Inc.

Read the full urinary tract infection testing devices market report here:

https://www.thebusinessresearchcompany.com/report/urinary-tract-infection-testing-devices-global-market-report

Which Region Is Forecast To Lead The Urinary Tract Infection Testing Devices Market In Terms Of Market Size?

North America was the largest region in the urinary tract infection testing devices market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urinary tract infection testing devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Urinary Tract Infection Testing Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20988&type=smp

Browse Through More Reports Similar to the Global Urinary Tract Infection Testing Devices Market 2026, By The Business Research Company

Medical Device Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-device-testing-global-market-report

Urinary Tract Infection Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/urinary-tract-infection-treatment-global-market-report

Medical Device Testing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-device-testing-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Urinary Tract Infection Testing Devices Market from 2026 to 2030?

The market for urinary tract infection testing devices has shown strong growth in recent years. It is projected to expand from $0.66 billion in 2025 to $0.71 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.3%. The historical increase in size can be attributed to the high prevalence of UTIs, growth in hospital diagnostic workloads, the adoption of routine urinalysis, the demand for quicker diagnosis, and the expansion of diagnostic laboratories.

The urinary tract infection testing devices market size is anticipated to experience robust expansion in the coming years. It is projected to increase to $0.9 billion by 2030, reflecting a compound annual growth rate (CAGR) of 6.2%. This growth throughout the forecast period can be ascribed to several factors, including the proliferation of point-of-care testing, the emergence of AI-assisted urine analysis, the rise in home diagnostics, escalating concerns over antimicrobial resistance, and advancements in rapid diagnostic kits. Significant developments expected during this period encompass rapid point-of-care UTI testing, the widespread adoption of automated urinalysis systems, the availability of home-based UTI testing kits, enhanced accuracy in bacterial detection, and improved antibiotic susceptibility screening.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20988&type=smp

What Drivers Are Affecting Demand In The Urinary Tract Infection Testing Devices Market?

The increasing occurrence of urinary tract infections (UTIs) is projected to boost the expansion of the urinary tract infection testing devices market. UTIs are defined as infections affecting any component of the urinary system, such as the kidneys, ureters, bladder, or urethra, predominantly stemming from bacterial pathogens, notably Escherichia coli. This rise in UTI cases is attributed to factors like extended catheterization, insufficient hygiene, and heightened antimicrobial resistance observed in hospital patients. These testing devices assist UTI patients by providing quick and precise diagnoses, empowering healthcare professionals to pinpoint infectious agents and promptly initiate specific treatments, which in turn lowers complications, enhances patient results, and curbs the dissemination of antimicrobial resistance in clinical environments. For example, in March 2024, the University of New South Wales, an Australian public research university, reported UTIs as highly common, with an estimated global incidence exceeding 400 million cases per year. Consequently, the expanding prevalence of urinary tract infections (UTIs) acts as a primary stimulant for the urinary tract infection testing devices market.

Which Segment Groups Are Influencing The Urinary Tract Infection Testing Devices Market?

The urinary tract infection testing devices market covered in this report is segmented –

1) By Product type: Instruments, Kits

2) By Test Type: Urinalysis, Urine Cultures, Susceptibility Testing

3) By End-User: Hospitals, Diagnostic Labs, Other End Users

Subsegments:

1) By Instruments: Automated UTI Analyzers, UTI Culture Systems, UTI Microscopes, UTI Diagnostic Devices (Handheld Devices)

2) By Kits: UTI Test Strips, UTI Reagents, Urine Culture Kits, UTI Home Testing Kits

Which Trends Are Expected To Influence The Urinary Tract Infection Testing Devices Market In The Upcoming Years?

Leading companies in the urinary tract infection testing devices market are concentrating on point-of-care (POC) testing devices to facilitate quicker, more convenient diagnoses and improve patient outcomes. Point-of-care (POC) testing devices are medical diagnostic tests performed at or near the patient care site, such as in a doctor’s office, at a hospital bedside, or even at home, removing the requirement to send samples to a laboratory. For instance, in June 2023, Sysmex Corporation, a Japan-based company specializing in urinary tract infection testing devices, introduced the PA-100 AST System, a Point-of-Care Testing System for detecting antimicrobial susceptibility. This system can identify the presence or absence of bacteria and evaluate the effectiveness of antimicrobials with a swift turnaround. It indicates the presence of growing bacteria in urine samples in approximately 10 minutes and delivers susceptibility test results in under 30 minutes. This capability enables healthcare professionals to conduct rapid testing directly from urine samples of patients suspected of having UTIs.

Who Are The Major Companies Operating In The Urinary Tract Infection Testing Devices Market?

Major companies operating in the urinary tract infection testing devices market are Cardinal Health Inc., F. Hoffmann‑La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, bioMérieux SA, Bio‑Rad Laboratories, QIAGEN NV, Sysmex Corporation, Quidel Corporation, ACON Laboratories Inc., Randox Laboratories Ltd., ARKRAY Inc., T2 Biosystems Inc., Cepheid, Meridian Bioscience Inc., Luminex Corporation, Beckman Coulter Inc., OraSure Technologies Inc., Mesa Biotech Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/urinary-tract-infection-testing-devices-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Urinary Tract Infection Testing Devices Market?

North America was the largest region in the urinary tract infection testing devices market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urinary tract infection testing devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Urinary Tract Infection Testing Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20988&type=smp

Browse Through More Reports Similar to the Global Urinary Tract Infection Testing Devices Market 2026, By The Business Research Company

Medical Device Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-device-testing-global-market-report

Urinary Tract Infection Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/urinary-tract-infection-treatment-global-market-report

Medical Device Testing Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-device-testing-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Urinary Tract Infection Testing Devices Market Size Likely To Evolve From 2025 Through 2034?

The market for devices used in testing urinary tract infections has experienced robust expansion recently; projections indicate this segment will expand from a valuation of $0.62 billion in 2024 to $0.66 billion the following year, reflecting a compound annual growth rate of 7.2%, this historical upward trajectory is primarily driven by the increasing worldwide burden of the disease, a mounting frequency of UTIs across the globe, the widespread presence of diabetes, particularly in countries with lower and middle incomes, a rise in infections acquired within healthcare settings, and the growing challenge posed by UTIs that resist antibiotics.

The market pertaining to urinary tract infection testing devices anticipates robust expansion over the coming years, projecting a valuation of $0.85 billion by 2029, reflecting a compound annual growth rate (CAGR) of 6.2%; this projected rise is fueled by the growing adoption of self-testing and at-home kits, a heightened demand for prompt diagnostic procedures, and the critical need to address escalating antibiotic resistance, while key developments shaping this period involve the incorporation of artificial intelligence and machine learning, leaps forward in point-of-care testing solutions, general technological progress, the emergence of diagnostics based on nanotechnology, and the introduction of tools utilizing CRISPR technology.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20988&type=smp

Which Drivers Are Shaping The Urinary Tract Infection Testing Devices Industry’s Market Share?

The escalating frequency of urinary tract infections (UTIs) is projected to be the primary catalyst fueling the expansion of the market dedicated to urinary tract infection testing equipment. These infections, which can affect any segment of the urinary tract such as the bladder, urethra, ureters, or kidneys, are predominantly bacterial in origin, with E. coli standing out as the chief causative agent. Factors contributing to the increased prevalence of UTIs include extended periods of catheterization, insufficient standards of personal hygiene, and rising resistance to antimicrobials among individuals receiving inpatient care. Diagnostic tools for UTIs are crucial as they facilitate swift and precise identification of these infections, enabling clinicians to pinpoint the exact pathogens involved and implement specific therapies without delay, resulting in fewer adverse events, better patient recovery, and a reduction in the dissemination of drug-resistant organisms in clinical environments. Illustratively, data from the University of New South Wales, an Australian public research institution, indicated in March 2024 that UTIs represent an extremely common ailment, affecting populations worldwide at a rate exceeding 400 million instances annually. Consequently, this high and increasing rate of UTIs is the direct impetus motivating the market for UTI testing apparatus.

What Are The Primary Types Of Segments Analyzed In The Urinary Tract Infection Testing Devices Market?

The urinary tract infection testing devicesmarket covered in this report is segmented –

1) By Product type: Instruments, Kits

2) By Test Type: Urinalysis, Urine Cultures, Susceptibility Testing

3) By End-User: Hospitals, Diagnostic Labs, Other End Users

Subsegments:

1) By Instruments: Automated UTI Analyzers, UTI Culture Systems, UTI Microscopes, UTI Diagnostic Devices (Handheld Devices)

2) By Kits: UTI Test Strips, UTI Reagents, Urine Culture Kits, UTI Home Testing Kits

Which Competitive Trends Are Defining The Urinary Tract Infection Testing Devices Market Structure?

Leading firms engaged in the market for urinary tract infection testing equipment are placing significant emphasis on developing point-of-care (POC) testing instruments, aiming to facilitate quicker and handier diagnostic procedures, thereby enhancing results for those affected. POC testing gadgets encompass medical analysis conducted right where the patient is receiving attention, which could be in a physician’s practice, adjacent to a hospital bed, or even within the patient’s residence, entirely bypassing the requirement to transport specimens to a laboratory setting. As an illustration, in the month of June 2023, Sysmex Corporation, a firm headquartered in Japan specializing in the creation of UTI testing apparatus, introduced the PA-100 AST System, a system designed for point-of-care testing intended to pinpoint antimicrobial sensitivity. This apparatus is capable of determining whether bacteria are present or absent and evaluating how well antimicrobials work in a brief timeframe. It communicates the detection of multiplying bacteria in urine specimens in about ten minutes and delivers outcomes from susceptibility testing in less than half an hour, enabling medical practitioners to conduct immediate analysis directly utilizing urine samples from individuals believed to have UTIs.

Who Are The Core Companies Influencing The Urinary Tract Infection Testing Devices Market Landscape?

Major companies operating in the urinary tract infection testing devices market are Cardinal Health Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthcare GmbH, Stryker Corporation, Laboratory Corporation of America Holdings, Biomerieux Pvt. Ltd., Coloplast A/S, Sysmex Corporation, Quidel Corporation, Teleflex Incorporated, Teleflex Incorporated, Bio-Rad Laboratories, QIAGEN NV, ACON Laboratories Inc., Randox Laboratories Ltd., ARKRAY Inc., T2 Biosystems Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/urinary-tract-infection-testing-devices-global-market-report

Which Region Is Projected To Lead The Urinary Tract Infection Testing Devices Market During The Forecast Period?

North America was the largest region in the urinary tract infection testing devices market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urinary tract infection testing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Urinary Tract Infection Testing Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20988&type=smp

Browse Through More Reports Similar to the Global Urinary Tract Infection Testing Devices Market 2025, By The Business Research Company

Urinary Stone Treatment Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/urinary-stone-treatment-devices-and-equipment-global-market-report

Urinary Drainage Bags Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/urinary-drainage-bags-global-market-report

Urinary Tract Infection Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/urinary-tract-infection-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Urinary Tract Infection Testing Devices Market Grown from 2024 to 2025?

Recent years have seen substantial growth in the market size for urinary tract infection testing devices. This market, beginning with a value of $0.62 billion in 2024, is projected to increase to $0.67 billion by 2025. This results in a compound annual growth rate (CAGR) of 6.9%. The notable growth during the historic period can be credited to various factors including an escalating disease burden, heightened global incidences of urinary tract infections, a surge in diabetes cases particularly in low-to-middle income countries, increased occurrences of hospital-acquired urinary tract infections, and a rising prevalence of urinary tract infections resistant to antibiotics.

What Growth Rate Is Anticipated for the Urinary Tract Infection Testing Devices Market in the Coming Years?

It is predicted that the market size of urinary tract infection testing devices will witness a robust increase in the coming years. The projection suggests a growth reaching $0.86 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 6.6%. Factors contributing to this growth include an upsurge in self-testing and at-home kits, a higher inclination towards early diagnosis and a growing need to fight antibiotic resistance. The forecast period is also expected to be marked by major trends such as the incorporation of AI and machine learning, innovations in home-based testing, technological progression, nano-diagnostics, and CRISPR-based diagnostic tools.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20988&type=smp

Who Are the Leading Companies in the Urinary Tract Infection Testing Devices Market?

Major companies operating in the urinary tract infection testing devices market are Cardinal Health Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthcare GmbH, Stryker Corporation, Laboratory Corporation of America Holdings, Biomerieux Pvt. Ltd., Coloplast A/S, Sysmex Corporation, Quidel Corporation, Teleflex Incorporated, Teleflex Incorporated, Bio-Rad Laboratories, QIAGEN NV, ACON Laboratories Inc., Randox Laboratories Ltd., ARKRAY Inc., T2 Biosystems Inc.

What Are the Key Drivers of the Urinary Tract Infection Testing Devices Market?

The urinary tract infection testing devices market is predicted to see significant growth due to the increasing number of urinary tract infections (UTIs). These infections, which occur in any part of the urinary system such as the kidneys, ureters, bladder, or urethra, are primarily caused by bacteria, with Escherichia coli being a common culprit. The rising number of UTIs can be attributed to factors such as extended catheter use, poor hygiene practices, and increased antimicrobial resistance among patients in hospitals. These UTI testing devices aid in providing quick and precise diagnostics for UTIs, thereby allowing healthcare professionals to determine the responsible pathogens and start relevant treatments swiftly. This swift intervention aids in reducing complications, improving patient outcomes, and controlling the spread of antimicrobial resistance within healthcare environments. For instance, a report from the University of New South Wales in Australia in March 2024 confirmed that UTIs are widespread infections, with global occurrences surpassing 400 million cases annually. Consequently, the escalating number of UTIs fuel the growth of the urinary tract infection testing devices market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20988&type=smp

What Are the Key Market Segments in the Urinary Tract Infection Testing Devices Industry?

The urinary tract infection testing devices market covered in this report is segmented –

1) By Product type: Instruments, Kits

2) By Test Type: Urinalysis, Urine Cultures, Susceptibility Testing

3) By End-User: Hospitals, Diagnostic Labs, Other End Users

Subsegments:

1) By Instruments: Automated UTI Analyzers, UTI Culture Systems, UTI Microscopes, UTI Diagnostic Devices (Handheld Devices)

2) By Kits: UTI Test Strips, UTI Reagents, Urine Culture Kits, UTI Home Testing Kits

What Are the Latest Trends in the Urinary Tract Infection Testing Devices Market?

Leading businesses in the urinary tract infection testing devices market are directing their attention towards point-of-care (POC) testing devices. The aim is to achieve faster, more efficient diagnoses, thus enhancing patient outcomes. Point-of-care (POC) testing devices are those medical diagnostic tests that are carried out either at or in close proximity to the patient care location. These could be a doctor’s clinic, a hospital bedside, or even a patient’s home, eliminating the necessity to dispatch samples to a lab for analysis. For example, in June 2023, Sysmex Corporation, a Japanese entity that produces urinary tract infection testing devices, introduced the PA-100 AST System. This is a point-of-care testing solution aimed at detecting antimicrobial susceptibility. This system is capable of identifying the presence or lack of bacteria and gauging the power of antimicrobials in a short span of time. The system presents the prevalence of growing bacteria in urine samples in about 10 minutes and discloses the susceptibility test results in less than 30 minutes. This empowers medical professionals to conduct immediate testing straight from urine samples of patients who are suspected to be suffering from UTIs.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/urinary-tract-infection-testing-devices-global-market-report

What Are the Key Regional Markets in the Urinary Tract Infection Testing Devices Industry?

North America was the largest region in the urinary tract infection testing devices market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urinary tract infection testing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20988

This Report Delivers Insight On:

1. How big is the urinary tract infection testing devices market, and how is it changing globally?

2. Who are the major companies in the urinary tract infection testing devices market, and how are they performing?

3. What are the key opportunities and risks in the urinary tract infection testing devices market right now?

4. Which products or customer segments are growing the most in the urinary tract infection testing devices market?

5. What factors are helping or slowing down the growth of the urinary tract infection testing devices market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Has The Urinary Tract Infection Testing Devices Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The market size of devices used for testing urinary tract infections has shown a robust growth in the past few years. The market, which is worth $0.62 billion in 2024, is expected to inflate to $0.67 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. The historical growth in the market is credited to the surge in disease rates, elevated cases of urinary tract infections worldwide, heightened occurrence of diabetes in low to middle income countries, an increase in hospital-acquired urinary tract infections, as well as a rise in the prevalence of antibiotic-resistant urinary tract infections.

The market for urinary tract infection testing devices is slated for impressive growth over the upcoming years, with the size expected to reach $0.86 billion in 2029, boasting a compound annual growth rate (CAGR) of 6.6%. Factors contributing to this projected growth include more people turning to self-testing kits and at-home options, greater emphasis on early diagnostics, and an intensifying need to tackle antibiotic resistance. Key trends expected during the forecast period involve integration of AI and machine learning, advancements in home-testing technology, overall technical innovations, diagnostics based on nanotechnology, and the use of CRISPR for diagnostic purposes.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20988&type=smp

Which Primay Drivers Are Accelerating Growth in the Urinary Tract Infection Testing Devices Market?

The surge in urinary tract infections (UTIs) is set to spur the increase of the urinary tract infection testing devices market. UTIs, which are prevalent in any part of the urinary system such as kidneys, ureters, bladder, or urethra, are usually caused by bacteria, with Escherichia coli being the most commonly found. They majorly occur due to the extended use of catheters, poor hygiene habits, and growing antimicrobial resistance among hospital patients. The urinary tract infection testing devices are pivotal in diagnosing UTIs swiftly and accurately. This quick diagnosis aids healthcare professionals to discover the causative pathogens promptly and instigate targeted treatments, thereby diminishing complications, enhancing patient outcomes, and limiting the dispersion of antimicrobial resistance in medical environments. For example, the University of New South Wales, a public research university in Australia, reported in March 2024 that UTIs are high-frequency infections, noting a global annual incidence surpassing 400 million cases. Hence, the surge in urinary tract infections (UTIs) propels the urinary tract infection testing devices market.

Which Primary Segments of the Urinary Tract Infection Testing Devices Market Are Driving Growth and Industry Transformations?

The urinary tract infection testing devices market covered in this report is segmented –

1) By Product type: Instruments, Kits

2) By Test Type: Urinalysis, Urine Cultures, Susceptibility Testing

3) By End-User: Hospitals, Diagnostic Labs, Other End Users

Subsegments:

1) By Instruments: Automated UTI Analyzers, UTI Culture Systems, UTI Microscopes, UTI Diagnostic Devices (Handheld Devices)

2) By Kits: UTI Test Strips, UTI Reagents, Urine Culture Kits, UTI Home Testing Kits

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20988&type=smp

Which Regions Are Key Players in the Growth of the Urinary Tract Infection Testing Devices Market?

North America was the largest region in the urinary tract infection testing devices market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urinary tract infection testing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Technological Trends Are Reshaping the Urinary Tract Infection Testing Devices Industry Dynamics?

Leading firms in the urinary tract infection testing devices market are concentrating their efforts on point-of-care (POC) testing devices. These tools are lauded for their speed and convenience in providing diagnoses, which has the effect of bettering patient outcomes. Point-of-care testing devices are medical diagnostic instruments that are used at the location of patient care, such as the doctor’s office, the patient’s bedside in the hospital, or even at home, thus eliminating the need to send samples to a lab. As an example, Sysmex Corporation, a Japan-based manufacturer of urinary tract infection testing devices, unveiled the PA-100 AST System, a Point-of-Care Testing System for identifying antimicrobial susceptibility, in June 2023. This system can discern the presence or absence of bacteria and gauge the efficacy of antimicrobials in a reduced timeframe. The device claims to detect bacterial growth in urine samples in roughly 10 minutes and can deliver susceptibility test results in less than 30 minutes. This capability encourages healthcare professionals to conduct swift testing directly from the urine samples of patients presumed to have urinary tract infections.

View the full report here:

https://www.thebusinessresearchcompany.com/report/urinary-tract-infection-testing-devices-global-market-report

What Parameters Are Used to Define the Urinary Tract Infection Testing Devices Market?

Urinary tract infection (UTI) testing devices are medical tools used to diagnose infections in the urinary system by detecting bacteria, white blood cells, or other markers in urine samples. These devices range from dipsticks and culture kits to advanced automated analyzers, providing rapid and accurate results to guide treatment decisions.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20988

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Are the Primary Drivers Supporting the Market Growth of theUrinary Tract Infection Testing Devices Market?

The upward trend in urinary tract infections (UTIs) is believed to spur the expansion of the urinary tract infection testing devices market in the future. Urinary tract infections (UTIs) refer to infections that affect any part of the urinary system, encompassing kidneys, ureters, bladder, or urethra, usually caused by bacteria, with Escherichia coli being the most prevalent pathogen. It is largely due to extended catheter usage, poor hygiene standards, and increased antimicrobial resistance among in-patients that the incidence of urinary tract infections (UTIs) has been growing. These testing devices for urinary tract infections provide a quick and precise diagnosis for patients suffering from UTIs, which allows medical professionals to promptly identify the pathogen responsible and provide appropriate treatments. This in turn leads to a reduction in complications, it enhances patient results and helps to curb the proliferation of antimicrobial resistance within healthcare environments. For example, in March 2024, a study by the University of New South Wales, a public research university based in Australia, revealed that UTIs are incredibly frequent occurrences with a projected global incidence of over 400 million cases annually. Therefore, the rising prevalence of urinary tract infections (UTIs) fuels the growth of the urinary tract infection testing devices market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20988&type=smp

#What is the Growth Potential of the Urinary Tract Infection Testing Devices Market, and How Will It Perform by 2034?

The market size for urinary tract infection testing devices has experienced robust growth in recent times. The market is projected to expand from $0.62 billion in 2024 to $0.67 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. Factors driving the growth in the historic period include an increase in disease burden, a rise in the worldwide occurrence of urinary tract infections, a high rate of diabetes in lower and middle-income countries, a surge in cases of hospital-acquired urinary tract infections, and a growing prevalence of antibiotic-resistant urinary tract infections.

The market for urinary tract infection testing devices is projected to witness substantial growth in the coming years, with its market value expected to reach $0.86 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.6%. This predicted growth during the forecast period is attributed to the prevalence of home and self-testing kits, a growing inclination towards early diagnosis, and a pressing need to tackle antibiotic resistance. The forecast period is also likely to see predominant trends such as the incorporation of AI and machine learning, innovations in home-based testing, technological advancements, diagnostics based on nanotechnology, and diagnostic tools reliant on CRISPR.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20988

What Are the Latest Innovations Influencing theUrinary Tract Infection Testing Devices Market?

Key players in the urinary tract infection testing devices market are emphasizing on point-of-care (POC) testing gadgets to ensure speedier and more convenient diagnostic procedures, which enhance patient results. POC testing instruments are utilized for medical diagnosis at or near the location of patient care, such as in a doctor’s clinic, next to a hospital bed, or even in the comfort of one’s home, eliminating the requirement to dispatch specimens to a laboratory. For example, Sysmex Corporation, a firm based in Japan that produces urinary tract infection testing apparatuses, unveiled the PA-100 AST System in June 2023, a point-of-care testing apparatus for spotting antimicrobial susceptibility. This system can identify the presence or absence of bacteria and evaluate the potency of antimicrobials in a relatively short time. It confirms the existence of proliferating bacteria in urine specimens in around 10 minutes and delivers susceptibility test outcomes in less than 30 minutes. This enables health care professionals to conduct prompt testing directly from the urine samples of individuals who may be suffering from urinary tract infections.

Who Are the Major Industry Players Accelerating Growth in theUrinary Tract Infection Testing Devices Market?

Major companies operating in the urinary tract infection testing devices market are Cardinal Health Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthcare GmbH, Stryker Corporation, Laboratory Corporation of America Holdings, Biomerieux Pvt. Ltd., Coloplast A/S, Sysmex Corporation, Quidel Corporation, Teleflex Incorporated, Teleflex Incorporated, Bio-Rad Laboratories, QIAGEN NV, ACON Laboratories Inc., Randox Laboratories Ltd., ARKRAY Inc., T2 Biosystems Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/urinary-tract-infection-testing-devices-global-market-report

Which Primary Segments of the Urinary Tract Infection Testing Devices Market Are Driving Growth and Industry Transformations?

The urinary tract infection testing devices market covered in this report is segmented –

1) By Product type: Instruments, Kits

2) By Test Type: Urinalysis, Urine Cultures, Susceptibility Testing

3) By End-User: Hospitals, Diagnostic Labs, Other End Users

Subsegments:

1) By Instruments: Automated UTI Analyzers, UTI Culture Systems, UTI Microscopes, UTI Diagnostic Devices (Handheld Devices)

2) By Kits: UTI Test Strips, UTI Reagents, Urine Culture Kits, UTI Home Testing Kits

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=20988&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theUrinary Tract Infection Testing Devices Market?# Market?

North America was the largest region in the urinary tract infection testing devices market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urinary tract infection testing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Urinary Tract Infection Testing Devices Market 2025, By The Business Research Company:

Urinary Stone Treatment Devices And Equipment Global Market Report 2025

https://thebusinessresearchcompany.com/report/urinary-stone-treatment-devices-and-equipment-global-market-report

Urinary Drainage Bags Global Market Report 2025

https://thebusinessresearchcompany.com/report/urinary-drainage-bags-global-market-report

Urinary Tract Infection Treatment Global Global Market Report 2025

https://thebusinessresearchcompany.com/report/urinary-tract-infection-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: